Roles of dopamine D1 receptors in Δ9-tetrahydrocannabinol-induced expression of Fos protein in the rat brain

Brain Research

Volumn 710, Issue 1-2, 1996, Pages 234-240

  Miyamoto, Akira ^a   Yamamoto, Tsuneyuki ^a   Ohno, Masuo ^a   Watanabe, Shigenori ^a   Tanaka, Hiroyuki ^a   Morimoto, Satoshi ^a   Shoyama, Yukihiro ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

D1 receptor; Fos protein; Rat; SCH 23390; 9 Tetrahydrocannabinol

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; CANNABINOID RECEPTOR; DOPAMINE 1 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; ONCOPROTEIN; SULPIRIDE; TETRAHYDROCANNABINOL; PROTEIN C FOS;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; GENE EXPRESSION; IMMUNOCYTOCHEMISTRY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; ANIMAL; BRAIN; DOSE RESPONSE; DRUG EFFECT; IMMUNOLOGICAL PROCEDURES; METABOLISM; PHYSIOLOGY; TISSUE DISTRIBUTION; WISTAR RAT;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; BRAIN; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; IMMUNOLOGIC TECHNIQUES; MALE; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D1; TETRAHYDROCANNABINOL; TISSUE DISTRIBUTION;

EID: 0029670563     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(95)01352-0     Document Type: Article

References (35)

1. Banerjee, S.P., Snyder, S.H. and Mechoulam, R., Cannabinoids: influence on neurotransmitter uptake in rat brain synaptosomes, J. Pharmacol Exp. Ther., 194 (1975) 74-81.
2. Carboni, E., Imperato, A., Perezzani, L. and Di Chiara, G., Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats, Neuroscience, 28 (1989) 259-266.
3. Chang, S.L., Squinto, S.P. and Harlan, R.E., Morphine activation of c-fos expression in rat brain, Biochem. Biophys. Res. Commun., 157 (1988) 698-704.
4. 9-Tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis, Psychopharmacology, 102 (1990) 156-162.
5. Church, W.H., Justice, J.B.J. and Byrd, L.D., Extracellular dopamine in rat striatum following uptake inhibition by cocaine, nomifensine and beztropine, Eur. J. Pharmacol., 139 (1987) 345-348.
6. 1 dopamine receptor activation of multiple transcription factor genes in rat striatum, J. Neurochem., 58 (1992) 1420-1426.
7. Devane, W.A., Dysarz, F.A., Johnson, M.R., Melvin, L.S. and Hewlett, A.C., Determination and characterization of a cannabinoid receptor in rat brain, Mol. Pharmacol., 34 (1988) 605-613.
8. Dragunow, M., Logan, B. and Laverty, R., 3,4-Methylenedioxymethamphetamine induces Fos-like proteins in rat basal ganglia: reversal with MK 801, Eur. J. Pharmacol., 206 (1991) 255-258.
9. Dragunow, M. and Robertson, H.A., Kindling stimulation induces c-fos protein(s) in granule cells of the rat dentate gyrus, Nature, 329 (1987) 441-442.
10. Fujiwara, M., Sakurai, Y., Kiyota, Y., Shimazoe, T., Ohta, H., Shibata, S. and Ueki, S., Behavioral pharmacology of amantadine with special reference to the effect on abnormal behavior in mice and rats, Folia Pharmacol. Japon., 85 (1985) 259-274 (in Japanese).
11. 9-tetrahydrocannabinol, J. Pharmacol. Exp. Ther., 272 (1995) 699-707.
12. Glass, M. and Dragunow, M., Induction of the Krox 24 transcription factor in striosomes by a cannabinoid agonist, NeuroReport, 6 (1995) 241-244.
13. Graybiel, A.M., Moratalla, R. and Robertson, H.A., Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striasome-matrix compartments and limbic subdivisions of the striaturn, Proc. Natl. Acad. Sci. USA, 87 (1990) 6912-6916.
14. Gubits, R.M., Smith, T.M., Fairhurst, J.L. and Yu, H., Adrenergic receptors mediate changes in c-fos mRNA levels in brain, Mol. Brain Res., 6 (1989) 39-45.
15. 3H-dopamine in rat brain tissue slices, Biochem. Pharmacol., 24 (1975) 847-852.
16. Herkenham, M., Lynn, A.B., Little, M.D., Johnson, M.R., Melvin, L.S., de Costa, B.R. and Rice, K.C., Cannabinoid receptor localization in brain, Proc. Natl. Acad. Sci. USA, 87 (1990) 1932-1936.
17. Herkenham, M., Lynn, A.B., Johnson, M.R., Melvin, L.S., de Costa, B.R. and Rice, K.C., Characterization and localization of cannabinoid receptors in rat brain: quantitative in vitro autoradiographic study, J. Neurosci., 11 (1991) 563-583.
18. Howlett, A.C., Reverse pharmacology applied to the cannabinoid receptor, Trends Pharmacol. Sci., 11 (1990) 395-397.
19. Koob, G.F., Drugs of abuse: anatomy, pharmacology and function of reward pathways, Trends Pharmacol. Sci., 13 (1992) 177-184.
20. Kornhauser, J.M., Nelson, D.E., Mayo, K.E. and Takahashi, J.S., Photic and circadian regulation of c-fos gene expression in the hamster suprachiasmatic nucleus, Neuron, 5 (1990) 127-134.
21. Mailleux, P., Verslype, M. and Preud'homme, X. and Vanderhaeghen, J.-J., Activation of multiple transcription factor genes by tetrahydrocannabinol in rat forebrain, NeuroReport, 5 (1994) 1265-1268.
22. Maisonneuve, I.M. and Glick, S.D., Interactions between ibogaine and cocaine in rats: in vivo microdialysis and motor behavior, Eur. J. Pharmacol., 212 (212) 263-266.
23. Matsuda, L.A., Lolait, S.J., Brownstein, M.J., Young, A.C. and Bonner, T.I., Structure of a cannabinoid receptor and functional expression of the cloned cDNA, Nature, 346 (1990) 561-564.
24. Morgan, J.I. and Curran, T., Proto-oncogene transcription factors and epilepsy, Trends Pharmacol. Sci., 12 (1991) 343-349.
25. 9-tetrahydrocannabinol on potassium-evoked release of dopamine in the rat caudate nucleus: an in vivo electrochemical and in vivo microdialysis study, Brain Research, 451 (1988) 59-68.
26. Nguyen, T.V., Kosofsky, B.E., Birnbaum, R., Cohen, B.M. and Hyman, S.E., Differential expression of c-Fos and Zif268 in rat striatum after haloperidol, clozapine, amphetamine, Proc. Natl. Acad. Sci. USA, 89 (1992) 4270-4274.
27. Poddar, M.K. and Dewey, W.L., Effects of cannabinoids on catecholamine uptake and release in hypothalamic and striatal synaptosomes, J. Pharmacol. Exp. Ther., 214 (1980) 63-67.
28. Rusak, B., Robertson, H.A., Wisden, W. and Hunt, S.P., Light pulses that shift rhythms induce gene expression in the suprachiasmatic nucleus, Science, 248 (1990) 1237-1240.
29. Saffen, D.W., Cole, A.J., Worley, P.F., Christy, B.A., Ryder, K. and Baraban, J.M., Convulsant-induced increase in transcription factor messenger RNAs in rat brain, Proc. Natl. Acad. Sci. USA, 85 (1988) 7795-7799.
30. Sagar, S.M., Sharp, F.R. and Curran, T., Expression of c-fos protein in brain: metabolic mapping at the cellular level, Science, 240 (1988) 1328-1331.
31. 9-Tetrahydrocannabmol facilitates striatal dopaminergic transmission, Pharmacol. Biochem. Behav., 33 (1989) 397-400.
32. [ 32] Shoyama, Y., Kohjimoto, Y. and Nishioka, I., Cannabis V. cannabigerolic acid monomethylester and cannabinolic acid, Chem. Pharm. Bull., 18 (1970) 1327-1332.
33. Sonnenberg, J.L., Mitchelmore, C., Macgregor-Leon, P.P., Hempstead, J., Morgan, J.I. and Curran, T., Glutamate receptor agonists increase the expression of Fos, Fra, and AP-1 binding activity in the mammalian brain, J. Neurosci. Res., 24 (1989) 72-80.
34. Torres, G. and River, C., Cocaine-induced expression of striatal c-fos in the rat is inhibited by NMDA receptor antagonists, Brain Res. Bull., 30 (1993) 173-176.
35. 1 receptors, Proc. Natl. Acad. Sci. USA, 88 (1991) 1291-1295.